Concepedia

Author

Ivan Budnik

Sheba Medical CenterORCID

Also Known As

Budnik, Ivan, I A Budnik, I. A. Budnik, I. Budnik, I.A. Budnik, I.A. Budnik Budnik, Ivan Budnik, J. Jonas, И. А. Будник, И.А. Будник

96

Publications

1.6K

Citations

16

H-Index

52

Concepts

All Affiliations

Sheba Medical CenterSechenov UniversityTel Aviv UniversityHolon Institute of TechnologySaratov State Medical University
IB

About

Ivan Budnik is an author at Sheba Medical Center specializing in medicine, hematology, and thrombosis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

183

2

Health Sciences

4

4

77

3

Biomedical Engineering

1

1

19

4

Cell Biology

1

1

14

5

Gastroenterology

1

1

11

Ivan Budnik

×

23

Publications

681

Citations

15

H-Index

YearCitations

Emicizumab prophylaxis among infants and toddlers with severe hemophilia A and inhibitors—a single‐center cohort

Assaf Arie Barg, Einat Avishai, Ivan Budnik,

Pediatric Blood & Cancer

2019

92

Emicizumab treatment and monitoring in a paediatric cohort: real‐world data

Assaf Arie Barg, Tami Livnat, Ivan Budnik,

British Journal of Haematology

2020

78

Emicizumab prophylaxis: Prospective longitudinal real‐world follow‐up and monitoring

Assaf A. Barg, Ivan Budnik, Einat Avishai,

Haemophilia

2021

68

Model of trauma-induced coagulopathy including hemodilution, fibrinolysis, acidosis, and hypothermia

Boris Shenkman, Ivan Budnik, Yulia Einav,

The Journal of Trauma: Injury, Infection, and Critical Care

2016

53

Real-World Data on Bleeding Patterns of Hemophilia A Patients Treated with Emicizumab

Sarina Levy‐Mendelovich, Tami Brutman‐Barazani, Ivan Budnik,

Journal of Clinical Medicine

2021

40

The impact of thrombin generation and rotation thromboelastometry on assessment of severity of factor XI deficiency

Tami Livnat, U. Martinowitz, Ariella Zivelin,

Thrombosis Research

2015

38

Emicizumab prophylaxis in haemophilia patients older than 50 years with cardiovascular risk factors: Real‐world data

Mudi Misgav, Tami Brutman‐Barazani, Ivan Budnik,

Haemophilia

2021

37

Thrombin generation as a predictor of thromboembolic events in multiple myeloma patients

Merav Leiba, Sarah Malkiel, Ivan Budnik,

Blood Cells Molecules and Diseases

2017

32

Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy

Irina S. Barequet, Dan Sachs, Boris Shenkman,

Journal of Cataract & Refractive Surgery

2011

28

The potential role of emicizumab prophylaxis in severe von Willebrand disease

Assaf Arie Barg, Einat Avishai, Ivan Budnik,

Blood Cells Molecules and Diseases

2020

27

Page 1